Index of reports
> Disability (71)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 71 Next >>
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 65.4 kg (143.8 pounds)
Reactions: Renal Failure
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Incivek
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Pegasys
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Other drugs received by patient: Zantac; Lisinopril; Ramipril
Possible Ribavirin side effects in male
Reported by a physician from Australia on 2012-08-14
Patient: male, weighing 88.0 kg (193.6 pounds)
Reactions: Deafness Neurosensory
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-24
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-28
Other drugs received by patient: Fungilin; Pristiq
Possible Ribavirin side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible Ribavirin side effects in 64 year old female
Reported by a pharmacist from United States on 2012-08-09
Patient: 64 year old female, weighing 84.1 kg (185.0 pounds)
Reactions: Dialysis, Hyperuricaemia, Renal Failure Acute
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Possible Ribavirin side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-08-02
Patient:
Reactions: Prostatitis, Autonomic Nervous System Imbalance, Anaemia, Hypotension, Malnutrition, General Physical Health Deterioration, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-09-27
End date: 2012-07-26
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-08-25
End date: 2012-07-26
Peginterferon Alfa-2B
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2011-08-25
End date: 2012-07-26
Other drugs received by patient: Isentress; Truvada
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-07-26
Patient:
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible Ribavirin side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20
Patient: 62 year old female
Reactions: Confusional State, Activities of Daily Living Impaired, Disorientation
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg, capsule, three times a day, oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-19
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Adverse Event
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-09-03
End date: 2012-05-13
Pegasys
Indication: Disease Recurrence
Start date: 2011-09-03
End date: 2012-05-13
Incivek
Dosage: 2 tablets 7-9 hrs apart
Victrelis
Dosage: 12 a day
Ribavirin
Dosage: (6) a day
Possible Ribavirin side effects in 53 year old male
Reported by a pharmacist from Canada on 2012-06-26
Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)
Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in 60 year old male
Reported by a pharmacist from United States on 2012-06-26
Patient: 60 year old male
Reactions: Angioedema
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: 500 mg;bid;
Indication: Hepatitis C
Victrelis
Dosage: 800 mg;q8h; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-04
Pegasys
Dosage: 180 mcg;qw;
Indication: Hepatitis C
Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril
Possible Ribavirin side effects in 61 year old male
Reported by a physician from United States on 2012-06-13
Patient: 61 year old male
Reactions: Gastrointestinal Motility Disorder, Pain, Impaired Work Ability, Emotional Disorder, Haemoglobin Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: bid
Indication: Hepatitis C
Start date: 2012-05-01
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2012-05-01
Other drugs received by patient: Vitamins E; Vitamins C
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: male
Reactions: Weight Decreased, Pruritus, Substance Use, Hunger, Abnormal Dreams, Back Pain, Polydipsia, Pain in Extremity, Eye Inflammation, Foreign Body Sensation in Eyes, Application Site Pain, Insomnia, Rash Erythematous, Pancreatitis, Injection Site Discolouration, Chills, Pain, Poor Quality Sleep, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Blood Glucose Increased, Decreased Appetite, Vomiting, Nausea, Musculoskeletal Chest Pain, Application Site Rash, Dysgeusia, Burning Sensation, Pollakiuria, Asthenia, Feeling Abnormal, Influenza
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2012-04-06
PEG-Intron
Indication: Hepatitis C
Start date: 2012-04-06
Possible Ribavirin side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: 50 year old male
Reactions: Haemoglobin Decreased, Dyspnoea, Arthralgia, Abdominal Distension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
PEG-Intron
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Megace; Zoloft
Possible Ribavirin side effects in male
Reported by a physician from Spain on 2012-06-08
Patient: male
Reactions: Erectile Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-02-25
End date: 2011-09-07
Ribavirin
Dosage: dosage: 1200 units not reported
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-02-25
End date: 2011-09-07
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient: male
Reactions: Tinnitus, Faecal Incontinence, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Indication: Hepatitis C
Start date: 2011-07-22
Victrelis
Indication: Hepatitis C
Start date: 2011-08-20
Possible Ribavirin side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 55 year old female
Reactions: Intention Tremor, Motor Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: qw
Indication: Hepatitis C
End date: 2011-12-01
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in male
Reported by a physician from Australia on 2012-05-31
Patient: male, weighing 88.0 kg (193.6 pounds)
Reactions: Deafness Bilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-24
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-28
Other drugs received by patient: Fungilin; Pristiq
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-05-29
Patient: male
Reactions: Retinal Exudates, Blindness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 4 df;tid;po
Administration route: Oral
Indication: Hepatitis C
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: male
Reactions: Gait Disturbance
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-13
End date: 2012-04-01
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-05-29
Patient: female
Reactions: Retinal Exudates, Blindness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2B
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 4 df, tid; po
Administration route: Oral
Indication: Hepatitis C
Possible Ribavirin side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23
Patient: 60 year old male
Reactions: Listless, Nausea, Anaemia, Rash, Abdominal Discomfort, Subretinal Haematoma, Syncope, Fatigue, Gastrointestinal Disorder, Insomnia, Vision Blurred, Dizziness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg; tid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-28
End date: 2012-04-30
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Other drugs received by patient: Nadolol
Possible Ribavirin side effects in female
Reported by a physician from Pakistan on 2012-05-15
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Dyspnoea, Gingival Bleeding, Hepatic Failure, Hyponatraemia, Altered State of Consciousness, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2010-01-18
End date: 2010-04-22
Ribavirin
Dosage: dose: 800
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-18
End date: 2010-04-22
Other drugs received by patient: Lexotanil
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: male
Reactions: Injection Site Discolouration, Weight Decreased, Pain, Chills, Substance Abuse, Hunger, Abdominal Pain Upper, Abnormal Dreams, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Decreased Appetite, Polydipsia, Back Pain, Vomiting, Pain in Extremity, Nausea, Eye Inflammation, Musculoskeletal Chest Pain, Dysgeusia, Burning Sensation, Rash Erythematous, Pollakiuria, Pancreatitis, Asthenia, Feeling Abnormal, Mobility Decreased, Influenza
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-04-06
Ribavirin
Indication: Hepatitis C
Start date: 2012-04-06
Telaprevir
Indication: Hepatitis C
Start date: 2012-04-06
Possible Ribavirin side effects in 48 year old female
Reported by a physician from France on 2012-05-11
Patient: 48 year old female
Reactions: Pancreatitis Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Alisporivir
Dosage: blinded
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-03
End date: 2009-11-05
Neupogen
Dosage: unk
Indication: Neutropenia
Start date: 2009-08-27
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-03
Peginterferon Alfa-2A
Dosage: 180 mug, qwk
Indication: Hepatitis C
Start date: 2009-02-03
Ramipril
Dosage: 10 mg, qd
Indication: Hypertension
Start date: 2009-08-27
Amlodipine Besylate
Dosage: 5 mg, qd
Indication: Hypertension
Start date: 2009-08-11
Other drugs received by patient: Neorecormon; Humalog; Zolpidem Tartrate
Possible Ribavirin side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02
Patient: 65 year old male
Reactions: Blood Count Abnormal, Gait Disturbance
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-13
End date: 2012-04-01
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from Venezuela on 2012-04-25
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Myalgia, Arthralgia, Anaemia, Mouth Ulceration, Neutropenia, Pyrexia, Asthenia, Epistaxis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-02-01
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
Possible Ribavirin side effects in 54 year old male
Reported by a physician from Germany on 2012-04-18
Patient: 54 year old male, weighing 95.0 kg (209.0 pounds)
Reactions: Pneumonia Aspiration, Blood Creatine Phosphokinase Increased, Respiratory Failure, Incorrect Dose Administered, Suicide Attempt, Toxicity To Various Agents, Depression
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: 200 mg
Indication: Hepatitis C
Boceprevir (Sch-503034)
Dosage: 200 mg
Indication: Hepatitis C
Interferon
Indication: Hepatitis C
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-04-11
Patient: male
Reactions: Haemorrhage, Hepatitis C, Increased Appetite, Hypotension, Rash, Somnolence, Fatigue, Joint Swelling, Oedema Peripheral, Aspartate Aminotransferase Increased, Vertigo, Dizziness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Telaprevir
Indication: Hepatitis C
Start date: 2011-09-01
Pegasys
Indication: Hepatitis C
Start date: 2011-09-01
Ribavirin
Indication: Hepatitis C
Start date: 2011-09-01
Possible Ribavirin side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2011-07-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Page 1 Next >>
|